Mutation analysis and association studies of the ubiquitin carboxyterminal hydrolase L1 gene in Huntington's disease

被引:76
作者
Nazé, P
Vuillaume, I
Destée, A
Pasquier, F
Sablonnière, B
机构
[1] Ctr Hosp Reg & Univ Lille, Hop R Salengro, Lab Biochim & Biol Mol, Unite Fonct Neurobiol, F-59037 Lille, France
[2] Ctr Hosp Reg & Univ Lille, Hop R Salengro, Neurol Clin, F-59037 Lille, France
关键词
Huntington's disease; ubiquitin carboxy-terminal hydrolase L1; modifying genes; mutations;
D O I
10.1016/S0304-3940(02)00231-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HID) is attributed to a triplet CAG repeat mutation, and about 70% of the variance in age-at-onset can be explained by the size of the repeat expansion. Among potential candidates as modifier genes, we investigated the role of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene. We examined the association of HID with the I93M mutation and S18Y polymorphism in 138 HID patients and 136 control subjects, but we did not identify the 193M mutation. The S18Y polymorphism was present in 17% of HID patients. Of the variance in the age-at-onset that was not accounted for by the CAG repeat, 13% could be attributed to S18Y polymorphism. We sequenced the entire coding region of the UCH-L1 gene in seven HID patients with unexplained older or younger onset age. The S18Y polymorphism was found in three out of the four patients presenting with a later age-at-onset. We conclude that the UCH-L1 gene may be a genetic factor that influences the variability in age-at-onset of HID. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 20 条
[1]   THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE [J].
ANDREW, SE ;
GOLDBERG, YP ;
KREMER, B ;
TELENIUS, H ;
THEILMANN, J ;
ADAM, S ;
STARR, E ;
SQUITIERI, F ;
LIN, BY ;
KALCHMAN, MA ;
GRAHAM, RK ;
HAYDEN, MR .
NATURE GENETICS, 1993, 4 (04) :398-403
[2]  
[Anonymous], 1991, HUNTINGTONS DIS
[3]  
Brinkman RR, 1997, AM J HUM GENET, V60, P1202
[4]  
FARRER LA, 1993, AM J HUM GENET, V53, P125
[5]   The lle93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease [J].
Harhangi, BS ;
Farrer, MJ ;
Lincoln, S ;
Bonifati, V ;
Meco, G ;
De Michele, G ;
Brice, A ;
Dürr, A ;
Martinez, M ;
Gasser, T ;
Bereznai, B ;
Vaughan, JR ;
Wood, NW ;
Hardy, J ;
Oostra, BA ;
Breteler, MMB .
NEUROSCIENCE LETTERS, 1999, 270 (01) :1-4
[6]   Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme [J].
Kalchman, MA ;
Graham, RK ;
Xia, G ;
Koide, HB ;
Hodgson, JG ;
Graham, KC ;
Goldberg, YP ;
Gietz, RD ;
Pickart, CM ;
Hayden, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19385-19394
[7]   The ubiquitin pathway in Parkinson's disease [J].
Leroy, E ;
Boyer, R ;
Auburger, G ;
Leube, B ;
Ulm, G ;
Mezey, E ;
Harta, G ;
Brownstein, MJ ;
Jonnalagada, S ;
Chernova, T ;
Dehejia, A ;
Lavedan, C ;
Gasser, T ;
Steinbach, PJ ;
Wilkinson, KD ;
Polymeropoulos, MH .
NATURE, 1998, 395 (6701) :451-452
[8]   Low frequency of pathogenic mutations in the ubiquitin carboxyterminal hydrolase gene in familial Parkinson's disease [J].
Lincoln, S ;
Vaughan, J ;
Wood, N ;
Baker, M ;
Adamson, J ;
Gwinn-Hardy, K ;
Lynch, T ;
Hardy, J ;
Farrer, M .
NEUROREPORT, 1999, 10 (02) :427-429
[9]   UBIQUITIN CARBOXYL-TERMINAL HYDROLASE (PGP 9.5) IS SELECTIVELY PRESENT IN UBIQUITINATED INCLUSION-BODIES CHARACTERISTIC OF HUMAN NEURODEGENERATIVE DISEASES [J].
LOWE, J ;
MCDERMOTT, H ;
LANDON, M ;
MAYER, RJ ;
WILKINSON, KD .
JOURNAL OF PATHOLOGY, 1990, 161 (02) :153-160
[10]   Evidence for the GluR6 gene associated with younger onset age of Huntington's disease [J].
MacDonald, ME ;
Vonsattel, MP ;
Shrinidhi, J ;
Couropmitree, NN ;
Cupples, LA ;
Bird, ED ;
Gusella, JF ;
Myers, RH .
NEUROLOGY, 1999, 53 (06) :1330-1332